These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1684222)

  • 81. Diversity and virulence thresholds in AIDS.
    de Boer RJ; Boerlijst MC
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):544-8. PubMed ID: 7904755
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Why do we not yet have a human immunodeficiency virus vaccine?
    Levine AJ
    J Virol; 2008 Dec; 82(24):11998-2000. PubMed ID: 18829744
    [No Abstract]   [Full Text] [Related]  

  • 83. How can viral variation be overcome?
    Cohen J
    Science; 1993 May; 260(5112):1260. PubMed ID: 8493566
    [No Abstract]   [Full Text] [Related]  

  • 84. AIDS conference in Berlin offers plenty of hidden gems.
    Cohen J
    Science; 1993 May; 260(5112):1262-3. PubMed ID: 8493568
    [No Abstract]   [Full Text] [Related]  

  • 85. Advancing an HIV vaccine; advancing vaccinology.
    Burton DR
    Nat Rev Immunol; 2019 Feb; 19(2):77-78. PubMed ID: 30560910
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Psychological influences on immunity. Implications for AIDS.
    Kiecolt-Glaser JK; Glaser R
    Am Psychol; 1988 Nov; 43(11):892-8. PubMed ID: 3063146
    [No Abstract]   [Full Text] [Related]  

  • 87. Psychoneuroimmunologic approaches to research on AIDS.
    Solomon GF
    Ann N Y Acad Sci; 1987; 496():628-36. PubMed ID: 3474994
    [No Abstract]   [Full Text] [Related]  

  • 88. Cell protein enhances AIDS-like infection.
    Mil Med; 1990 May; 155(5):A13. PubMed ID: 2114571
    [No Abstract]   [Full Text] [Related]  

  • 89. Involvement of human leukocyte antigen class I molecules in human immunodeficiency virus infection of CD4-positive cells.
    Benkirane M; Blanc-Zouaoui D; Hirn M; Devaux C
    J Virol; 1994 Oct; 68(10):6332-9. PubMed ID: 7916059
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.
    Johnson PR; Montefiori DC; Goldstein S; Hamm TE; Zhou J; Kitov S; Haigwood NL; Misher L; London WT; Gerin JL
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2175-9. PubMed ID: 1549578
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2.
    Biberfeld G; Thorstensson R; Putkonen P
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330
    [No Abstract]   [Full Text] [Related]  

  • 92. AIDS response.
    Nature; 1991 Dec; 354(6353):439-40. PubMed ID: 1684222
    [No Abstract]   [Full Text] [Related]  

  • 93. AIDS. Escape from the immune system.
    Walker BD; Goulder PJ
    Nature; 2000 Sep; 407(6802):313-4. PubMed ID: 11014174
    [No Abstract]   [Full Text] [Related]  

  • 94. Alternative HIV vaccine strategies.
    Lehner T; Shearer GM
    Science; 2002 Aug; 297(5585):1276-7. PubMed ID: 12194176
    [No Abstract]   [Full Text] [Related]  

  • 95. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.